JAPAN ATOMIC INDUSTRIAL FORUM, INC.

for Japanese

ATOMS in JAPAN

26 November, 2019

Hitachi Receives Order from Mayo Clinic to Build First Carbon Ion Treatment System in North America

On November 20, Japan’s Hitachi, Ltd. announced that it had reached an agreement with the Mayo Clinic, in principle, to build North America’s first carbon ion treatment facility. The system will be constructed at the Mayo Clinic’s campus in Jacksonville, Florida, one of its three oncology centers, the others being in Minnesota and Arizona.

Upon the announcement, Gianrico Farrugia, M.D., president and CEO of the Mayo Clinic, said, “Carbon ion therapy has tremendous potential as a tool for treating patients with challenging cancers that do not respond well to currently available therapies.”

Keiji Kojima, executive vice president of Hitachi and in charge of its Smart Life Sector of Hitachi, expressed the firm’s desire to promote the system internationally, saying, “We are confident through our carbon experience, digital technology and the existing partnership with Mayo Clinic that we will continue to contribute to cancer treatment and increase our customer’s social value in the United States and across the globe.”

Domestically, Hitachi delivered the carbon ion treatment system to the Osaka Heavy Ion Therapy Center (HyBEAT) in 2018. Its first international order for the system came the same year, from the Taiwan Veterans General Hospital in Taipei.

Clinical tests of the carbon ion therapy system began in 1994 at the National Institute for Quantum and Radiological Science and Technology’s (QST’s) Heavy Ion Medical Accelerator in Chiba (HIMAC)—the pioneering device for charged-particle cancer therapy—as the world’s first specialized facility.

Subsequently, treatments have been carried out at the aforementioned HyBEAT in Osaka, as well as at Gunma University, the Kanagawa Cancer Center, the Hyogo Ion Beam Medical Center, and the Saga Heavy Ion Medical Accelerator in Tosu, Saga Prefecture, on the island of Kyushu.

According to a report presented by the QST in October to the Japan Atomic Energy Commission (JAEC), carbon ion therapy facilities are being increasingly provided primarily to other Asian countries by Hitachi and Toshiba Corporation, along with the Chinese Academy of Sciences’ Institute of Modern Physics. In South Korea, too, Toshiba’s system is expected to be put into service in 2022.

Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

SNS facebooktwitter

NPPs Map

Video

“The current situation at Fukushima Daiichi NPS” -From 3.11 toward the future- (ver, Jan. 2020)

23 January, 2020
“The current situation at Fukushima Daiichi NPS” -From 3.11 toward the future- (ver, Jan. 2020)07:47

Recent News

7 August, 2020
Nuclear Powered Ship Mutsu Designated as Special “Ship Heritage”
3 August, 2020
On Taking Office as JAIF President
3 August, 2020
Nuclear Energy Buyers Guide in Japan 2020-21 is now available
31 July, 2020
Thoughts on the Decision to Approve Changes to the Reprocessing Business
31 July, 2020
NRA Permits JNFL to Alter Rokkasho Reprocessing Plant, Its Having Complied with New Regulatory Standards
30 June, 2020
“Existing NPPs to Enter Age of 80-Year Operations” JAIF Annual Survey Says
16 June, 2020
Toshiba ESS and Yokohama National University Boost Joint Research to Upgrade Heavy-Ion Cancer Therapy, Using Kanagawa Prefectural Facility
8 June, 2020
NRA Grants Permission to Make Changes to Reactor Installation at HTTR under New Regulatory Standards
22 May, 2020
Sendai-2 Starts Periodic Inspection, with Due Date Imminent to Install Specific Safety Facilities
15 May, 2020
NRA Issues Draft Review Report for Rokkasho Reprocessing Plant
▲TOP